Publications dans lesquelles il/elle collabore avec CRISTINA SARASQUETA EIZAGUIRRE (27)

2024

  1. Worldwide Prevalence and Description of Cyclic Vomiting Syndrome According to the Results of the Rome Foundation Global Epidemiology Study

    American Journal of Gastroenterology

2022

  1. Incidence and evolution of foreign body impaction in the upper gastrointestinal tract and its relationship with eosionophilic oesophagitis

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 4, pp. 274-281

2020

  1. Colorectal cancer survival in 50-to 69-year-olds after introducing the faecal immunochemical test

    Cancers, Vol. 12, Núm. 9, pp. 1-14

  2. Impact of the faecal immunochemical test on colorectal cancer survival

    BMC Cancer, Vol. 20, Núm. 1

2019

  1. Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions

    European Journal of Gastroenterology and Hepatology, Vol. 31, Núm. 3, pp. 312-315

2018

  1. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia

    United European Gastroenterology Journal, Vol. 6, Núm. 1, pp. 123-130

  2. Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test

    European Journal of Public Health, Vol. 28, Núm. 6, pp. 1143-1148

2017

  1. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

2016

  1. Effect of pravastatin on the survival of patients with advanced gastric cancer

    Oncotarget, Vol. 7, Núm. 4, pp. 4379-4384

  2. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

    Digestive and Liver Disease, Vol. 48, Núm. 5, pp. 542-551

2015

  1. Colorectal cancer in a second round after a negative faecal immunochemical test

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 7, pp. 813-818

2014

  1. Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions

    European Journal of Gastroenterology and Hepatology, Vol. 26, Núm. 12, pp. 1380-1384

  2. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337

  3. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

    Cancer Causes and Control, Vol. 25, Núm. 8, pp. 985-997

  4. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4

2013

  1. Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test

    Mayo Clinic Proceedings

  2. Evaluation of Alpha 1-Antitrypsin and the Levels of mRNA Expression of Matrix Metalloproteinase 7, Urokinase Type Plasminogen Activator Receptor and COX-2 for the Diagnosis of Colorectal Cancer

    PLoS ONE, Vol. 8, Núm. 1

  3. Prognosis and follow-up of 135 patients with ischemic colitis over a five-year period

    World Journal of Gastroenterology, Vol. 19, Núm. 44, pp. 8042-8046

  4. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals

    Gastrointestinal Endoscopy, Vol. 78, Núm. 2

  5. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori

    Clinical Microbiology and Infection, Vol. 19, Núm. 4, pp. 379-383